New technologies delivered to your inbox Subscribe
1999-033 – These methods reduce the audible sound produced by ultrasound scanners in patients. Reduction of fetal stress during ultrasound examination.
1998-097 – A method is described that allows both highly sensitive screening for arterial disease in conjuction with highly specific diagnoses on an MR System with high-speed gradients.
1998-076 – Short term paralysis of underlying musculature to improve cutaneous wound healing in tramatic and non-tramatic wounds.
1998-071 – Substrates for SULT1A1 are; 4-nitrophenol, 17beta-estradiol (E2), diethylstilboestrol (DES), 1-naphol, 4-hydroxytamoxifen, minoxidil, estrone (E1), epinephrine, dopamine, acetaminophen, genistein, other monocyclic phenols. The gene is ubiquitously expressed but especially prominent in liver but also lung, brain, platelet, prostate, placenta, and adrenal gland. Diseases associated with... Read More
1998-066 – The Mayo Clinic is developing and testing a synbiotic (composition of synergistic probiotic organisms and a prebiotic) for clinical indications (Croh'n’s, IBD, immunocompromised patients, patients undrgoing chemo or radiation therapy, patients infected with antibiotic resistant organisms. THe synbiotic has proven to be very effective in several animal trials including animals that were... Read More
1998-060 – A stent that fractures at strategic points to relieve arterial stress after placement.
1998-036 – Histamine N-methyltransferase (HNMT, EC126.96.36.199) catalyzes a major pathway in the metabolism of histamine. The only pathway for the termination of the neurotransmitter actions of histamine in the human CNS is N-methylation catalyzed by HNMT, and approximately 70% of histamine in bronchial epithelium is metabolized by HNMT. Mayo investigators have cloned the cDNA and gene for HNMT in humans and... Read More
1998-026 – Mutations in the tau gene have been discovered that are linked to Tau pathologies. Identification of these mutations can lead to animal models of neurodegenerative diseases to be developed and provides methods for determining a diagnosis of neurodegenerative disease in a patient.
1998-009 – Multiple myeloma is a universally fatal plasmaproliferative disorder despite aggressive chemotherapy and transplantation. An immunotherapeutic approach to target myeloma cells for killing by toxin genes or radioisotopes may be very useful therapeutically in myeloma and such approaches have already been shown to have clinical activity in other malignancies. Our investigators have devised a... Read More
1997-112 – An inbred strain of transgenic mice that show tissue-specific expression of the human MUC1 gene. These animals express a form of the human MUC1 gene which codes for the core protein of a mucin expressed by glandular epithelia and carcinomas which develop from these tissues. The core protein is underglycosylated in these cancers and therefore represents a possible target for immunotherapy.... Read More
1997-109 – System for clinical image display.
1997-106 – Mayo researchers have established several human multiple myeloma cell lines, including the ANBL-6, KP-6, KAS-6/1 and DP-6 lines.
1997-103 – Expanding screw with increased strength of bone-screw interface for spinal internal fixation surgeries.
1997-071 – We generated an HLA-DR4ß(NT) transgene construct in which positions 110 and 139 were altered to resemble endogenous mouse H2 Aß molecules. This construct was introduced into (B10 x SWR) embryos, and DR4ß(NT) transgenic mice were produced. The transgene was transferred into B10.RFB3 (Eß0 Ealphap) mice. The transgene-encoded DR4ß molecules paired with endogenous Ealpha chains to form stable... Read More
1997-069 – We developed an HLA-DR2 mouse model by introducing a human DRB1*1502(DR2DW12) transgene into CIA susceptible BIO.RQB3 (H2A8) mice. These mice showed a significant reduction in the incidence and severity of arthritis. For further information please see Human Immunology, 1996, 50:54-60.
1997-035 – This technology is a T-cell line that lacks the protein tyrosine kinase, ZAP-70. ZAP-70 plays a critical role in the initiation of lymphocyte activation responses to antigenic stimuli. The cell line can be used to define the mechanisms of ZAP-70 activation and function in T-cell signaling. This line can be used also to confirm the mechanism of action of ZAP-70 targeted drugs. This is the... Read More
1997-001 – With the aging of the population, osteoporosis is emerging as a major public health problem. Drugs used to treat osteoporosis can be classified into those that decrease bone resorption and those that increase bone formation. While a number of anti-resorptive therapies for osteoporosis are presently available, there is a clear need for novel anabolic approaches. New insights gained from a... Read More
1996-112 – Enable clinicians to selectively cool the brain, independent of core temperature, as a means of cerebral protective therapies.
1996-106 – Mayo has issued patent claims for inhibiting hydroxymethylglutaryl coA reductase activity to slow heart valve degeneration.
1996-076 – Transgenic mouse (Tg2576) carrying the Swedish mutation for Alzheimer’s Disease. This mouse was developed by Dr. Karen Hsiao Ashe at the University of Minnesota and is exclusively licensed to Mayo. This mouse develops age-related neuropathology, including development of amyloid plaques and behavioral changes, and can be used in research related to Alzheimer’s Disease and other... Read More
1995-155 – HFOBER cells are hFOBs stably transfected with human estrogen receptor; subclones HFOB/ER-3 and HFOB/ER-4 express levels of estrogen receptor consistent with the range of levels measured in human osteoblasts. The HFOBER cell lines have a complete concatenation of transcription factors such that the estrogen receptor is transactionally active; estrogen-regulated functions are maintained. The... Read More
1995-140 – Transgenic mouse models for asthma were developed that express interleukin-5 under the control of a lung epithelial specific promoter. All mice express abnormally high levels of eosinophils in those regions and display symptoms consistent with the underlying physiologic conditions. The CCIL-5 mouse line is a superb animal model for the study of asthma. The animals show hyperactivity to... Read More
1995-139 – Transgenic mouse models for eosinophil-mediated tissue inflammation were developed that express interleukin-5 under the control of a T-cell specific promoter. All mice express abnormally high levels of eosinophils in those regions and display symptoms consistent with the underlying physiologic conditions. The NJ1638 mice are models for hypereosinophilic syndromes and have high levels of... Read More
1995-110 – These radiolabeled agents are designed to allow for simple preparation of radioactive markers for measuring colonic transit without the need for an Investigational New Drug application (IND). These radiolabeled agents can be used to evaluate patients with suspected colonic motility disorders.
1995-102 – Detection with the use of broad range primers and the PCR assay for the detection of the WA-1 Agent.
1995-094 – In this system, a low frequency radiation force is exerted point-by-point on the object by a confocal ultrasound transducer. The amplitude of the resulting acoustic field is used to produce a two-dimensional display of the object’s cross sections. This system can produce a high resolution image from an object based on its low frequency (kHz) characteristics.
1995-087 – The base sequence coding for the protein of the human kappa opioid receptor, the deduced amino acid sequence and the cell line transfected with the gene expressing the protein.
1995-055 – Imaging of Tubular Structures; Systems and methods have been developed for imaging tubular structures in the body using 2D and/or 3D.
1995-051 – Sequence analysis has been used to select synthetic peptides for use in the development of rabbit polyclonal antibodies against each of the known human cytosolic sulfotransferase enzymes. These antibodies, in turn, can be used to characterize these enzymes for both research purposes and in the development of drugs that are metabolized by sulfatino in humans.
1994-072 – The invention provides an isolated and purified human DNA molecule that encodes human estrogen sulfotransferase (EST, SULT1E1). It also provides cell lines and vectors containing human estrogen sulfotransferase DNA that can be used to express the enzyme. The enzyme is useful for screening drugs that are metabolized by human estrogen sulfotransferase.
1993-058 – Open reading frame gene sequence of the neurotensin receptors from human brain tissue.
1993-010 – Conditionally Immortalized Human Osteoblastic Cell Line: Normal human bone cells were stably transfected with a gene encoding a temperature-sensitive mutant (tsA58) of SV40 large T antigen; cells proliferate as if immortalized at 33.5C degrees but differentiate at 39.5C degrees; hFOB cells show normal bone cell characteristics with regard to responses to dihydroxyvitamin D3 and PTH, BMP’s,... Read More
1988-049 – HMC-1 is a one-of-a kind human cell line which can serve as a resource for mast cell proteins including granule proteins and mast cell genetic material (DNA and RNA). The HMC-1 line was derived from a patient with mast cell leukemia and we believe it is comprised of immature mast cells. These cells may not respond in all ways as would mature mast cells. HMC-1 cells lack a functional IgE... Read More
1987-046 – Monoclonal Antibody to Bromo-deoxy-uridine. Useful in cell proliferation kits
2006-281 – Time-resolved MRI acquisition methods like TRICKS and BRISK allow for accelerated temporal resolution by acquiring some of the raw data less frequently than a fully sampled method. The proposed method gives a quantitive criterion for which data are most important, and which other data can be skipped with minimal impact. It is shown that for a time-resolved, 3D volume acquisition, up to 70% of... Read More